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The expansion of brain size is accompanied by a relative enlargement 
of the subventricular zone during development. Epithelial-like 
neural stem cells divide in the ventricular zone at the ventricles of 
the embryonic brain, self-renew and generate basal progenitors1 that 
delaminate and settle in the subventricular zone in enlarged brain 
regions2. The length of time that cells stay in the subventricular 
zone is essential for controlling further amplification and fate 
determination. Here we show that the interphase centrosome 
protein AKNA has a key role in this process. AKNA localizes at the 
subdistal appendages of the mother centriole in specific subtypes of 
neural stem cells, and in almost all basal progenitors. This protein 
is necessary and sufficient to organize centrosomal microtubules, 
and promote their nucleation and growth. These features of AKNA 
are important for mediating the delamination process in the 
formation of the subventricular zone. Moreover, AKNA regulates 
the exit from the subventricular zone, which reveals the pivotal 
role of centrosomal microtubule organization in enabling cells to 
both enter and remain in the subventricular zone. The epithelial-
to-mesenchymal transition is also regulated by AKNA in other 
epithelial cells, demonstrating its general importance for the control 
of cell delamination.
We searched the developing mouse cerebral cortex for candidate 
regulators of SVZ generation and expansion3–5. We chose to examine 
AKNA because levels of Akna mRNA correlate with the time at which 
the subventricular zone (SVZ) is generated (that is, low at embryonic 
day (E)11, high at E14 and low at E18), and because neural stem cells 
(NSCs) isolated at the peak of SVZ generation have higher levels of Akna 
when transitioning to basal progenitors3 (Extended Data Fig. 1a, b). 
To investigate the function of AKNA, we first generated monoclonal 
antibodies, which were validated by RNA interference (Extended Data 
Fig. 1c–f, Methods). Given the annotation of AKNA as an AT-hook 
transcription factor6, we were surprised to find specific immunoflu-
orescence signals at centrosomes (Fig. 1a, Extended Data Fig. 1f–m) 
in different cell types of various species (Extended Data Figs. 1–4, 8, 
10), which was confirmed by BAC-transgenic cell lines (Extended Data 
Fig. 1h) and fractionation of cell lysates (Extended Data Fig. 1n, o). 
Ultrastructural analysis (Extended Data Fig. 2a–c) showed that AKNA 
largely localized to the distal part of the subdistal appendages (SDAs) 
of the mother centriole in interphase; some AKNA was also found 
at the proximal ends of centrioles and along microtubules (Extended 
Data Fig. 2a–d, Supplementary Video 1). Recombinant AKNA protein 
decorated in vitro-reconstituted microtubules (Extended Data Fig. 2e, 
Supplementary Video 2). The centrosomal localization of AKNA is 
not dependent on microtubules or cargo-motors (Extended Data 
Fig. 2f–h); however, it is dependent on centrioles, as AKNA is absent 
upon deletion of SAS47 (Extended Data Fig. 2i) and the SDA protein 
ODF2 (Extended Data Fig. 2j, k). AKNA localizes to the centrosome 
through its carboxy terminal part—a region that was omitted from its 
first description6 (see Supplementary Discussion)—as AKNA(1–1080), 
which lacks the C-terminal 324 amino acids, is distributed in the 
cytoplasm but is still able to bind to microtubules (Extended Data 
Fig. 2l–o). Similar to most SDA-associated proteins8, AKNA dissociates 
from centrosomes during M-phase without proteolytic degradation 
(Extended Data Figs. 1h panel 2, 3a, b) and reassembles at the cen-
trosomes during late telophase and early G1 phase (Supplementary 
Video 3); this dissociation and reassembly is regulated by phospho-
rylation (Extended Data Fig. 3c, d). Thus, AKNA is a novel integral 
component of centrosomal SDAs and binding to microtubules, which 
raises the question of what its role is during development.
AKNA+ centrosomes showed their highest signal at E14 (compare 
Fig. 1b with Extended Data Fig. 4a–c), were most frequent in the SVZ 
(Fig. 1b, Extended Data Fig. 4c), and there was almost no AKNA sig-
nal in the cortical plate (in which neurons differentiate). In NSCs at 
the ventricular surface, only a fraction of centrosomes were AKNA+ 
(Fig. 1b, Extended Data Fig. 4d–f). These AKNA+ centrosomes were 
in PAX6+TBR2+ differentiating NSCs9, which is consistent with higher 
levels of Akna mRNA in this population9 (Extended Data Fig. 4g, h). 
Thus, AKNA exhibits an unprecedented subtype specificity, being 
restricted to the centrosomes of differentiating NSCs and basal progen-
itors in forebrain development.
Knockdown of AKNA, mediated by short hairpin (sh)RNA, 
(Extended Data Fig. 1d) via in utero electroporation (IUE) in E13 
cortices led to the retention of GFP+ cells in the ventricular zone 
with more self-renewing (PAX6+TBR2−) NSCs relative to the control 
conditions, under which many GFP+ cells had left the ventricular 
zone and SVZ by two days post-electroporation (d.p.e.) (Fig. 1c–f, 
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Supplementary Video 4). This phenotype was observed with two dif-
ferent shRNAs, was rescued by co-electroporating AKNA (Fig. 1e, 
Extended Data Fig. 5a, b) and was independent of p53-mediated cell 
death (Extended Data Fig. 5c–j). Thus, AKNA loss of function impairs 
NSC delamination, and leads to the retention of more NSCs in the 
ventricular zone.
Conversely, AKNA overexpression induced a fast delamination, 
with most GFP+ cells being found in the SVZ at 1 d.p.e. (Fig. 1g–i); 
this resulted in more basal progenitors (PAX6−TBR2+) and NEUN+ 
neurons and a concomitant decrease in NSCs (PAX6+TBR2−), as 
compared to controls (Fig. 1j, Extended Data Fig. 5k). The increased 























































































































































Fig. 1 | AKNA is a centrosome component that regulates NSC 
delamination. a, Immunostaining of E14 cortex (CTX) cells, showing 
AKNA at the mother centriole together with ODF2 (distal and subdistal 
appendages) and GT335 (cilia and centrioles) (n = 4). b, E14 cortex 
sections showing AKNA+ subsets of centrosomes. Pericentrin+ (PCNT+)
AKNA+ centrosomes (blue arrows) at the ventricular zone (VZ) (panel 3); 
many AKNA+ centrosomes in the SVZ and intermediate zone (IZ) (panel 
2); and most centrosomes AKNA− (red arrows) in the cortical plate (CP)  
(panel 1). V, ventricle. n = 12. c, d, g, h, Confocal micrographs  
illustrating binning and the distribution of control (c, g), Akna shRNA  
no. 1 (shAkna 1) (d), electroporated GFP+ cells at 2 d.p.e. and AKNA  
overexpression (OE) at 1 d.p.e. (h). e, f, i, j, Quantifications as indicated  
in panels. e, i, Mean ± s.e.m. as transparent band in the same colour.  
f, j, Box plots show median, quartiles (box) and range (whiskers).  
e, Control shRNA, n = 6; Akna shRNA no. 1, n = 5; Akna shRNA no. 2 
(shAkna 2), n = 5 embryos. *P ≤ 0.05, **P ≤ 0.01 (exact P values (from 
top to bottom) 0.00796, 0.00432, 0.00865, 0.02217, 0.03174, 0.01731, 
0.00432, 0.00865 and 0.00865). f, Control shRNA, n = 5; Akna shRNA no. 
2, n = 5 embryos. NS, not significant, **P ≤ 0.01 (exact P values (from left 
to right) 0.00793, 0.30952 and 0.00793). i, GFP (control), n = 9; AKNA 
overexpression, n = 11; AKNA(1–1080), n = 4 embryos. **P ≤ 0.01, 
***P ≤ 0.001 (exact P values (from top to bottom) 0.00779, 0.00147 and 
0.00008). j, GFP (control), n = 4; AKNA overexpression, n = 4 embryos. 
NS, not significant, *P ≤ 0.05 (exact P values (from left to right), 0.02857, 
0.48571 and 0.02857). e, f, i, j, Two-sided Mann–Whitney U test. Scale 
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Fig. 2 | AKNA regulates microtubule organization in NSCs. a, Images 
of E14 cortical cells transfected with shRNA control or Akna shRNA 
no. 2, in nocodazole-based microtubule repolymerization assays. The 
yellow dashed line indicates a cell in which microtubules did not grow 
upon AKNA knockdown. b, Box plot, median, quartiles (box) and 
range (whiskers), showing reduced number of cells with centrosomal 
microtubule (MT) regrowth after AKNA knockdown (shRNA control, 
n = 4; Akna shRNA no. 2, n = 4 independent experiments, P = 0.02857). 
c, Dot and violin plot showing reduced length of microtubule. Dots 
represent single measurements, mean ± s.e.m in bold in the centre. 
shRNA control, n = 110; Akna shRNA no. 2, n = 92 microtubule 
endpoints from 4 independent experiments each (P = 0.00007).  
d, AKNA overexpression clusters organize microtubules independently 
of centrosomes (see also Extended Data Fig. 6b) (n = 6). e, Most GFP+ 
electroporated cells lose their integration into the apical cadherin belt 
at the ventricle (V) 18 h after AKNA overexpression (n = 3 embryos). 
f, Line graph illustrating the distribution of GFP+ cells 24 h after IUE. 
Mean ± s.e.m. as transparent band in the same colour. GFP (control), 
n = 9; AKNA overexpression, n = 11; AKNA and E-cadherin (E-CAD) 
overexpression, n = 3 embryos. GFP (control) and AKNA overexpression 
is based on the same data as shown in Fig. 1i. *P ≤ 0.05, **P ≤ 0.01, 
***P ≤ 0.001 (exact P values (from top to bottom) 0.02597, 0.00779, 
0.00909 and 0.00008). g, h, En face view of ventricular endfeet in E14 
cortex delineated by ZO-1 (g), quantified in h, showing the inverse 
correlation of AKNA immunofluorescence intensity and endfoot size. 
Transparent band depicts the best-fit curve with the 95% confidence 
interval (n = 76 cells from 4 embryos). i, Dot and violin plot (dots represent 
individual cells, mean ± s.e.m. in bold in the centre) depicting the reduced 
size of the apical endfeet after AKNA overexpression. GFP (control), n = 76 
cells; AKNA overexpression, n = 14 cells; n = 4 embryos each; P = 0.00339. 
b, c, f, i, Two-sided Mann–Whitney U test. Scale bars, 5 μm.
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not occur in vitro (Extended Data Fig. 5l), and is therefore due to the 
altered niche that is encountered upon delamination in vivo. Live 
imaging in cortical slices showed that AKNA overexpression acceler-
ated NSC delamination by a retraction of the apical processes without 
cell division (28% (n = 33) compared to 3% (n = 165) in controls) 
(Supplementary Video 5). Thus, AKNA-induced delamination occurs 
in interphase, during which AKNA localizes at centrosomes. Consistent 
with this, overexpression of AKNA(1–1080) hardly increased delam-
ination (Fig. 1i), which indicates the importance of the centrosomal 
localization of this protein.
Given the function of SDAs10 in microtubule organization, we 
tested whether AKNA regulates microtubule organization using 
nocodazole-based microtubule regrowth assays (Extended Data 
Fig. 6a). shRNA-mediated AKNA knockdown in primary cortical 
cells resulted in a significant reduction in the number of cells with 
centrosomal microtubule regrowth, and of microtubule-fibre length 
(Fig. 2a–c). Independently of centrosomes, microtubule asters ema-
nated from ectopic AKNA bodies upon AKNA overexpression (Fig. 2d) 
in an apparently size-dependent manner (Extended Data Fig. 6b). 
Importantly, AKNA efficiently recruited components of the γ-tubulin 
ring complex (γTuRC), such as TUBG and GCP4, as well as CKAP5 
(also known as ch-TOG) (the mammalian homologue of the micro-
tubule nucleator and polymerase XMAP21511), but not other centro-
some- and microtubule-associated proteins (Extended Data Fig. 6c, d); 
this demonstrates the specificity of γTuRC and microtubule nucleation 
factor recruitment, and how AKNA affects microtubule nucleation and 
growth. AKNA also recruits and co-immunoprecipitates with SDA 
proteins that are involved in microtubule organization such as EB1 (also 
known as MAPRE1), DCTN1 (also known as P150-Glued), dynein and 
ODF212,13 (Extended Data Fig. 6e, f). AKNA is thus a novel regulator 
of the centrosome, controlling microtubule organizing centre (MTOC) 
activity specifically in differentiating NSCs. Notably, AKNA does not 
affect cilia formation or length in NSCs, despite its localization at SDAs 
(Extended Data Fig. 7a–d).
Interestingly, CAMSAP3—a microtubule minus-end binding pro-
tein—was recruited to AKNA+ foci (Extended Data Fig. 6e). Consistent 
with CAMSAP proteins anchoring non-centrosomal microtubules 
at epithelial junctions14, CAMSAP3 was enriched at the NSC junc-
tions at the ventricular surface (Extended Data Fig. 7e), and cadherin 
levels at the apical surface were reduced after AKNA overexpression 
(Fig. 2e). However, maintaining high levels of cadherin with AKNA 
and E-cadherin co-IUE was not sufficient to interfere with the AKNA-
induced delamination process (Fig. 2f). At the junctions surrounding 
the apical endfoot at the ventricular surface, microtubule and actin belts 
mediate abscission15. High levels of AKNA at the centrosome correlated 
with a smaller size of apical endfeet, delineated by ZO-1 immunos-
taining (Fig. 2g, h), and AKNA overexpression increased the number 
of cells with small endfeet (Fig. 2i). Thus, AKNA regulates the delam-
ination process by increasing centrosomal MTOC activity, weakening 
junctional complexes and promoting contraction of the apical endfoot.
As AKNA also binds directly to microtubules, we monitored micro-
tubule dynamics by EB3–GFP live imaging in cortex slices after IUE in 
vivo. EB3–GFP comets grew mostly in a basal direction in NSCs after 
GFP IUE, as previously shown16; however, after AKNA overexpression, 
comets displayed more random directions (Extended Data Fig. 8a, b, 
Supplementary Videos 6, 7), which indicates a change in the orienta-
tion of microtubule growth and a repositioning of the MTOC toward 
non-apical positions (see schematic in Extended Data Fig. 7j). AKNA 
overexpression also had minor effects on the speed of EB3–GFP comets 
(Extended Data Fig. 8c). To determine possible direct effects of AKNA 
on microtubules, we reconstituted microtubules in a centrosome-free 
environment in vitro. The presence of AKNA affected growth velocity 
but not microtubule lifetime (Extended Data Fig. 8d–f, Supplementary 
Video 2). Moreover, once a depolymerizing microtubule encountered 
a site of AKNA enrichment, the depolymerization velocity was signifi-
cantly reduced (Extended Data Fig. 8g, Supplementary Video 2), which 
demonstrates that AKNA affects microtubule dynamics in vivo and in 
vitro. These dynamics are important for delamination, as stabilizing 
microtubules using Taxol in vivo blocked the AKNA-induced delami-
nation (Extended Data Fig. 8h).
As the delamination from the ventricular zone resembles the epi-
thelial–mesenchymal transition (EMT)17–19, we asked whether AKNA 
is more generally relevant for EMT by monitoring normal murine 
mammary gland (NMuMG) epithelial cells during EMT induced by 
transforming growth factor beta-1 (TGFβ1)20,21. Centrosomal AKNA 
levels are low in untreated NMuMG cells, but upregulated early in 
EMT (Extended Data Fig. 8i–k). As expected14, NMuMG cells show 
largely non-centrosomal microtubule polymerization before EMT 
(Supplementary Video 8), and AKNA overexpression increased 
microtubule nucleation at the centrosome (Extended Data Fig. 8l, 
Supplementary Video 9). Knockdown of AKNA using small interfering 
(si)RNAs (Extended Data Fig. 8m) had no effect on the expression of 
core EMT transcription factors Twist1, Zeb2, Snai1 and Snai2 during 
EMT (Extended Data Fig. 8i), but led to ZO-1 retention at cell junctions 
and counteracted the TGFβ1-induced disassembly of these junctions 
(Fig. 3a–d, Extended Data Fig. 8o, p). AKNA knockdown also atten-
uated the rearrangement of actin fibres from the junctions to stress 
fibres (Fig. 3a–c), showing the importance of AKNA in fully dissolving 
these junctional complexes during EMT. Immunostaining confirmed 
that AKNA is sufficient to significantly reduce CAMSAP3 at the junc-
tional interface closest to AKNA+ foci upon overexpression, but not 
CAMSAP3 at more-distant junctions (Fig. 3e, f, Extended Data Fig. 8q). 
Conversely, AKNA knockdown resulted in the retention of CAMSAP3 
at cell junctions after TGFβ1-induced EMT (Fig. 3g, Extended Data 
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Fig. 3 | EMT progression requires AKNA to dissolve cell junctions.  
a–c, Micrographs of NMuMG cells in untreated (a) and in TGFβ1-treated, 
EMT-inducing conditions with control siRNA (siControl) (b) or Akna 
siRNA (siAkna) (c). ZO-1 is retained at cell junctions, and actin filaments 
(phalloidin) redistribute less frequently from junctions to cytoplasm, upon 
AKNA knockdown during EMT. d, Dot and box plot showing ZO-1 signal 
at the cell junction (position 0) (untreated, n = 60 cells; TGFβ1-treated 
and control siRNA, n = 55 cells; TGFβ1-treated and Akna siRNA, n = 76 
cells from 3 independent experiments). NS, not significant, ***P ≤ 0.001 
(exact P values (from left to right) 5.2 × 10−6, 0.93189 and 0.00004).  
f, g, Dot and box plots showing significant reduction in CAMSAP3 at the 
cell junction close to AKNA foci after AKNA overexpression (position 1 in 
the micrograph in e) but not in EMT with Akna siRNA. In f, untransfected, 
n = 26 cells; AKNA overexpression: n = 22 cells, from 3 independent 
experiments. P = 0.00003. In g, untreated, n = 42 cells; TGFβ1-treated and 
control siRNA, n = 51 cells; TGFβ1-treated and Akna siRNA, n = 50 cells, 
from 3 independent experiments. NS, not significant, ***P ≤ 0.001 (exact 
P values (from left to right) 0.00086, 0.75728 and 0.00095). d, f, g, Two-
sided Mann–Whitney U test; box plots show median, quartiles (box) and 
range (whiskers). Scale bars, 10 μm.
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Fig. 8r). Thus, AKNA mediates the remodelling of junctional com-
plexes by recruiting CAMSAP3 from junctional microtubules to the 
centrosome, thereby destabilizing junctional cadherins22 and enabling 
cells to detach during EMT.
Besides the role of AKNA in the EMT-like delamination of NSCs, 
we aimed to determine its function within the SVZ, the region with 
highest levels of AKNA (only 10% of centrosomes were AKNA+ above 
the SVZ in the cortical plate where neurons are located) (Extended 
Data Fig. 4e). Accordingly, neurons isolated in vitro showed a greater 
degree of non-centrosomal microtubule polymerization (Extended 
Data Fig. 9a, b), as compared to NSCs. To counteract the reduction 
in levels of AKNA above the SVZ, we expressed Akna cDNA under 
the late basal progenitor and neuron-specific doublecortin (Dcx) pro-
moter (Extended Data Fig. 9c) at E13. This resulted in many GFP+ 
cells remaining below the cortical plate, as compared to control 
(Fig. 4a–d), without affecting proliferation at two days post-electropo-
ration (Fig. 4e) or neuronal differentiation (Extended Data Fig. 9d–f). 
Conversely, Dcx-promoter-driven Akna microRNAs (miRNAs) did 
not affect cells that left the SVZ and reached normal positions within 
the cortical plate, similar to controls (Extended Data Fig. 9g, h). Thus, 
the downregulation of AKNA that occurs physiologically (Fig. 1b, 
Extended Data Fig. 4d, e, g) facilitates the transition of neurons from 
the SVZ to the cortical plate.
To determine at which step AKNA levels are critical in the transi-
tion from multipolar SVZ cells to bipolar neurons migrating into the 
cortical plate23 (schematic in Extended Data Fig. 7i), we performed 
live imaging in slices after AKNA overexpression or knockdown in 
vivo. Control and knockdown cells had similar migratory speeds during 
locomotion (Fig. 4f), but knockdown cells transitioned faster from the 
multipolar SVZ morphology to the bipolar morphology of migrating 
neurons (Fig. 4g, h). Conversely, many cells with AKNA overexpres-
sion retained a multipolar morphology and migrated less frequently 
(Fig. 4i, j, Supplementary Video 10). Thus, AKNA is key not only in 
bringing cells into the SVZ but also in retaining them there. These data 
provide further support for the suggestion that the switch to bipolar 
morphology and radial neuronal migration requires a switch from a 
centrosomal to more non-centrosomal MTOC via endogenous down-
regulation of AKNA. Indeed, the mutant, non-centrosome-localizing 
form of AKNA (that is, AKNA(1–1080)) expressed under the Dcx  
promoter failed to retain cells in the SVZ (Fig. 4a–c), which highlights 
the importance of the centrosomal location of AKNA in this process 
of morphology switching and migration.
In neurons, microtubules originate preferentially from other 
non-centrosomal compartments24, allowing axon and dendrite 
formation25,26, and have more stable detyrosinated and acetylated 
microtubules27,28. AKNA counteracts these neuronal hallmarks by 
promoting centrosomal microtubule nucleation, faster microtubule 
growth, and more dynamic and less detyrosinated microtubules 
(Extended Data Fig. 8m, n). Therefore, the downregulation of AKNA 
is required for neurons to migrate into the cortical plate. Thus, micro-
tubule organization differs profoundly for cell migration into the SVZ, 
which requires AKNA and a centrosomal MTOC, versus migration out 
of the SVZ, which requires the loss of AKNA.
During the delamination process, AKNA orchestrates the disas-
sembly of junctional complexes as well as apical endfoot constriction. 
As microtubule stabilization by Taxol blocked the AKNA-induced 
delamination, microtubule dynamics and rearrangement are critical. 
Moreover, the centrosomal localization of AKNA is important, as the 
non-centrosomal form, AKNA(1–1080), showed impaired delamina-
tion but could still bind microtubules. AKNA increased centrosomal 
microtubule nucleation by recruiting γTuRC and CKAP511. This—
together with the low-level direct binding of AKNA to microtubules—
explains why AKNA gain of function both promotes nucleation and 
inhibits depolymerization. AKNA recruits CAMSAP3 to the centro-
some. This microtubule minus-end binding protein otherwise tethers 
microtubules to the adherens junctions14 contributing to adherens 
junction stability22 and cell–cell attachment29. Thus, AKNA orches-
trates the delamination process by increasing centrosomal microtubule 
nucleation and recruiting nucleation factors and minus-end stabilizers, 



































































































































































































Fig. 4 | AKNA regulates retention of cells within the SVZ. a, b, Confocal 
micrographs illustrating binning and the distribution of electroporated 
cells expressing GFP (a), Akna and GFP, or Akna(1–1080) and GFP (b) 
under the control of the Dcx promoter at 5 d.p.e. c, Line graph illustrating 
the distribution of GFP+ cells after IUE (mean ± s.e.m. as transparent 
band in the same colour). Dcx-GFP, n = 5; Dcx-Akna, n = 4; Dcx-
Akna(1–1080), n = 4 embryos. *P ≤ 0.05 (exact P values (from top to 
bottom) 0.02857, 0.02857, 0.01587, 0.01587, 0.02857 and 0.01080).  
d, e, Dot and box plots showing the fraction of GFP+ cells retained below  
the cortical plate labelled by TBR1 at 5 d.p.e. (d, Dcx-GFP, n = 5; Dcx-
Akna, n = 3 embryos, P = 0.03571) or in cell cycle (KI67+) at 2 d.p.e.  
(e, Dcx-GFP, n = 4; Dcx-Akna, n = 4 embryos; not significant (P = 0.48571). 
f, Dot and violin plot showing the migration speed of control and AKNA-
knockdown neurons in slices at 2 d.p.e. (dots represent individual cells, 
mean ± s.e.m. in bold) (Dcx-miRNA(neg) (sequence predicted not to target 
any known vertebrate gene), n = 34; Dcx-miRNA(Akna), n = 26 cells, from 
3 independent experiments; not significant (P = 0.67299)). g–j, Box plots 
illustrating the morphological transitions of control and AKNA-knockdown 
cells (g, h, n = 4 embryos each condition) or after AKNA overexpression  
(i, j, n = 3 embryos in each condition). B, bipolar; M, multipolar; PB, 
persisting bipolar; PM, persisting multipolar. In g–j, NS, not significant, 
*P ≤ 0.05, **P ≤ 0.01. Exact P values (from left to right): 0.02460 and 
0.02460 (g); 0.75566, 0.93038 and 0.71203 (h); 0.00385 and 0.00385 (i); 
0.99877, 0.71153 and 0.75539 (j). c–f, Two-sided Mann–Whitney U test;  
g–j, two-sided Student’s t-test. Box plots show median, quartiles (box) and 
range (whiskers). Scale bars, 50 μm.
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mediating constriction of the apical endfoot. The recruitment of 
AKNA to the centrosome is post-translationally regulated; SOX4 reg-
ulates Akna mRNA in EMT21 and the generation of basal progeni-
tors30 (Extended Data Fig. 10a–c). Regulating AKNA levels orchestrates 
delamination and retention in the SVZ—this process is particularly 
relevant in species with highly proliferative cells2 in an enlarged SVZ 
(Extended Data Fig. 10d–r). Thus, the function of AKNA in ontogeny 
may have profound relevance in phylogeny.
Reporting summary
Further information on research design is available in the Nature Research 
Reporting Summary linked to this paper.
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Extended Data Fig. 1 | AKNA expression, centrosome localization and 
antibody verification. a, Quantitative PCR with reverse transcription (RT-
qPCR) data show higher levels of Akna mRNA in E14 cerebral cortex than 
in E11 or E18 cerebral cortex (n = 3 biologically independent samples, 
mean ± s.e.m., one-way ANOVA with Tukey’s post hoc test. b, Microarray 
data depicting higher expression of AKNA in NSCs that generate basal 
progenitors (CD133+, hGFAP–GFPhigh (transgenic mice expressing GFP 
under control of the human GFAP promoter)3 (hGFAP–GFP, n = 4; 
hGFAP-GFPlow, n = 3 independent samples, mean ± s.e.m., two-sided 
Student’s t-test, note that all GFAP–GFP+ cells were double-stained for 
CD133 prior to FACS (see ref. 3). c, Western blot of AKNA in E14 cerebral 
cortex lysate running at a higher-than-predicted (153 kDa) molecular 
mass, owing to phosphorylation (data not shown, see also Extended Data 
Fig. 3d) (n = 8 independent experiments). d, e, Western blot of AKNA 
in Neuro2a cell lysates after transfection with Akna shRNA no. 1, Akna 
shRNA no. 2 or control shRNA (d, n = 2 independent experiments) or 
3 different miRNAs and control (e, 1 experiment), using the antibody 
clone 14D7. f, AKNA immunofluorescence using clone 25F1 in primary 
E14 cortical cells, which show TBR2+ basal progenitors that lack AKNA 
immunofluorescence signal upon transfection with Akna siRNAs but not 
with control siRNA, demonstrating the specificity of the immunostaining 
(n = 3 independent experiments). g, Immunofluorescence of AKNA and 
TUBG in primary E14 cortical cells, showing AKNA signal surrounding a 
single TUBG+ centriole (n > 10 independent experiments). h, A20 BAC 
transgenic cell line showing GFP-tagged AKNA at centrosomes marked 
by TUBG in interphase (h′ and h′′′) but not during mitosis (h′′) (n = 3 
independent experiments). i, Predicted domains of mouse AKNA protein. 
j, Amino acid sequence of AT-hook-containing transcription-factor 
domain of AKNA, and of the AT-hook-like domain. Note that AKNA 
lacks the GRP core sequence surrounded by several K and R amino acids, 
which is required for DNA- or RNA-binding AT-hook domains (such as 
the AT-hook domains of HMGA1). k–m, Immunostaining of dissociated 
cerebral organoid cells derived from human induced pluripotent stem 
cells (hiPSCs), showing AKNA localization at centrosomes with 3 different 
monoclonal antibodies (n = 2 independent experiments each). Clone  
9G1 and 4F5 recognize epitopes in the N- and C-terminal parts of the 
protein, respectively, which suggests that different splice variants6,31 still 
localize at centrosomes. One (mother) centriole is enriched for AKNA.  
n, Western blot of AKNA in nuclear and cytoplasmic cell fractions of A20 
cells, showing AKNA signal in the cytoplasm only (n = 2 independent 
experiments). o, Mass spectrometric analysis of sucrose-gradient-based 
isolated cellular sub-fractions of A20 cells. AKNA is enriched in fractions 
3 and 4, which contain the centrosomal components listed on the right 
side (1 experiment). Scale bars, 5 μm (f, h, k–m), 2.5 μm (g).
 31. Sims-Mourtada, J. C. et al. The human AKNA gene expresses multiple 
transcripts and protein isoforms as a result of alternative promoter usage, 
splicing, and polyadenylation. DNA Cell Biol. 24, 325–338 (2005).
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Extended Data Fig. 2 | Mechanisms of AKNA localization.  
a, b, Electron microscopy micrographs showing AKNA immunogold-
labelling at SDAs in the SVZ (a) and ventricular zone (b) of E13 cerebral 
cortex sections; b′, a magnification of the boxed area showing an SDA 
in b (n = 3 embryos). c, Stimulated emission depletion nanoscopy 
image showing AKNA immunofluorescence signal surrounding ODF2 
immunofluorescence signal; this reveals the more-distal localization of 
AKNA at the SDA, as compared to ODF2, which localizes proximally 
with respect to the centriole in E14 brain NSCs (summarized in the 
schematic below; AKNA, green, ODF2, magenta) (n = 2 independent 
experiments). d, Micrographs showing DNA points accumulation for 
imaging in nanoscale topography super-resolution images of AKNA 
and TUBA, illustrating that AKNA is present along microtubules in E14 
cortical cells (n = 3 independent experiments). e, Coomassie staining 
of a sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS–
PAGE) gel showing samples of purified in vitro polymerized tubulin, 
with and without addition of purified recombinant AKNA as indicated 
(n = 2 independent experiments). Note that full-length AKNA co-
precipitates with polymerized tubulin (lane 4), showing that AKNA is 
able to bind microtubules in vitro. f–h, E14 primary cortical cells treated 
with DMSO (f), nocodazole (g) or DCTN2 overexpression (h) show 
AKNA immunofluorescence remaining at centrosomes after microtubule 
depolymerization (n = 4 (f, g) and 3 (h) independent experiments).  
i, Micrographs showing AKNA immunofluorescence signal at centrosomes 
at the apical, ventricular surface in sections of E14 wild-type, but not 
Sas4−/−p53−/− (Sas4 is also known as Cenpji, and p53 is also known 
as Trp53) mice that lack centrioles7 (n = 2 independent experiments). 
Note that PCNT+ pericentriolar material is present in the absence of 
centrioles in Sas4−/−p53−/− mice. j, k, AKNA immunofluorescence of 
wild-type (j) or CRISPR–Cas9-generated Odf2 knock-out (k) mammary 
epithelial cells, showing that AKNA is lost from centrioles lacking 
SDAs (n = 3 independent experiments each). l, Schematic of different 
truncated AKNA variants used to analyse sub-cellular localization, 
as indicated to the right. m, n, Micrographs showing examples of the 
localization of truncated AKNA forms expressed in primary E14 cortical 
cells. Constructs containing the last 370 amino acids (n) localize to 
centrosomes, whereas AKNA(1–1080) is not localized at the centrosome 
(square) and is mainly cytoplasmic (m) (n = 3 independent experiments 
each). Notably, the clone used6 to first characterize AKNA lacked the 
C-terminal centrosome-targeting part. o, Representative images obtained 
from total internal reflection fluorescence (TIRF) time-lapse recordings of 
microtubules assembled in vitro from bovine brain tubulin, labelled with 
Cy5 in the presence of AKNA(1–1080)–GFP. BRB80 buffer with high salt 
concentration (100 mM KCl) was used to rule out unspecific binding to 
microtubules (n = 2 independent experiments). These data demonstrate 
that AKNA is an integral component of SDAs, is able to bind microtubules 
and is not recruited to centrosomes by microtubule or dynein–dynactin 
motors. Scale bars, 0.1 μm (a–c), 2 μm (d), 3 μm (o), 5 μm (f–h, m), 10 μm 
(i–k, n).
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Extended Data Fig. 3 | AKNA dissociates from the centrosome during 
mitosis and upon increased phosphorylation. a, Immunofluorescence 
of AKNA in primary E14 cortical cells at different phases of the cell cycle, 
showing the lack of AKNA immunofluorescence at the centrosome during 
mitosis (n = 3 independent experiments). b, Western blot of AKNA in 
synchronized A20 cells, showing that AKNA protein is not degraded 
during mitosis (as indicated by the presence of phospho-histone H3) 
(n = 2 independent experiments). c, Representative micrographs of AKNA 
and PCNT immunofluorescence in E14 primary cortical cells treated 
with 500 nM okadaic acid (OA). Note that AKNA immunofluorescence is 
observed at centrosomes at 0 h but is undetectable in most cells 3 h after 
treatment, which shows that the centrosomal localization of AKNA is 
phosphorylation-dependent (n = 3 independent experiments). d, Western 
blot of lysates of OA-treated cells shows that phosphorylation—here 
caused by protein phosphatase inhibition—shifts that AKNA band on 
SDS–PAGE, and subsequently leads to protein degradation as observed 
in lysates of cells 5 h after OA washout (n = 3 independent experiments). 
Scale bars, 5 μm (a), 10 μm (c).
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Extended Data Fig. 4 | Temporal and sub-type-specific regulation of 
AKNA in the developing telencephalon. a–c, Micrographs showing  
that PCNT+ centrosomes lack AKNA in the cerebral cortex at E9  
(a, n = 2 experiments) and E18 (b, n = 2 experiments), whereas AKNA 
is enriched in the ventricular zone and—specifically—the SVZ at E14 
in the ganglionic eminence (c, n > 10 experiments) and the cerebral 
cortex (Fig. 1). d, Distribution of AKNA+ centrosomes in the E14 cortex 
(n = 3 independent experiments). e–g, Plots showing the percentage of 
AKNA+ centrosomes in E14 and E13 cerebral cortex regions as indicated 
(e, f, n = 3 independent experiments), and in dissociated primary E14 
cortical cells (g), which reveals that cells with AKNA+ centrosomes are 
mostly differentiating NSCs (PAX6+TBR2+) and PAX6−TBR2+ basal 
progenitors (n = 3 independent experiments). EM, electron microscopy; 
IF, immunofluorescence. h, Micrographs of cells isolated from E14 cerebral 
cortex by FACS using prominin 1, and stained for PAX6 (red arrows) and 
TBR2 (blue arrows). This shows that double-positive (differentiating) 
NSCs have AKNA+ centrosomes, whereas PAX6+TBR2− (proliferating) 
NSCs do not (n = 2 experiments). Data in d–g are presented as 
mean ± s.e.m. Scale bars, 10 μm (a, c, h), 20 μm (b).
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Extended Data Fig. 5 | AKNA knock down elicits cell death, and 
delamination defects persist upon cell-death rescue by p53 reduction. 
a, Confocal micrographs showing staining of E14 cortex one day after 
co-IUE of membrane-tagged mKO2 (monomeric Kusabira-Orange2) 
and cytoplasmic GFP. Note that the vast majority of cells electroporated 
with one plasmid also express the marker of the second plasmid (n = 4 
embryos). b, Line graph illustrating the distribution of GFP+ cells in 
the cerebral cortex after IUE for control shRNA (n = 6 embryos), Akna 
shRNA no. 1 (n = 5 embryos) and co-IUE of Akna shRNA and AKNA 
overexpression (0.2 μg μl−1) (n = 3 embryos). Note that the effect of 
AKNA knockdown is rescued with the appropriate amount of Akna 
expression, and is therefore specific. c–e, Micrographs showing TUNEL 
staining in E15 cerebral cortex, indicating cell death two days after IUE 
with Akna shRNA no. 1 (d, n = 3 embryos) or Akna shRNA no. 2  
(d, n = 3 embryos) but not with control plasmids (c, n = 4 embryos).  
f, Dot and box plot showing the TUNEL+ area per electroporated (GFP+) 
area with control shRNA (n = 4 embryos) and Akna shRNA (n = 6 
embryos, Akna shRNA no. 1 and Akna sRNA no. 2). g, h, Micrographs 
showing the distribution of GFP+ cells in E15 cerebral cortex two days 
after IUE with control shRNA (g) or Akna shRNA no. 2 plus p53 miRNA 
plasmids (h). Note that p53 downregulation rescues the apoptotic effect 
of AKNA knockdown. i, Line graph illustrating the distribution of GFP+ 
cells in the cerebral cortex after control shRNA (n = 6 embryos), p53 
miRNA (n = 4 embryos), and Akna shRNA no. 2 and p53 miRNA (n = 4, 
embryos) IUE, showing the delamination defect that occurs upon AKNA 
knockdown is also present when apoptosis is blocked (Akna shRNA 
no. 2 and p53 miRNA). Note that p53 knockdown on its own does not 
alter the distribution of GFP+ cells. j, Dot and box plot showing the 
decrease of GFP+TBR2+ cells after IUE of Akna shRNA-positive, p53 
miRNA, as compared to control; this shows that defects in delamination 
are accompanied by retaining an NSC fate (control shRNA, n = 6; Akna 
shRNA no. 2 and p53 miRNA, n = 8 embryos). k, Dot and box plot 
showing a decrease in proliferating (KI67+, n = 4 embryos each), and a 
concomitant increase in differentiated, NEUN+ cells analysed at E14 after 
IUE at E13 (GFP, n = 3; AKNA overexpression, n = 5 embryos). l, Box 
plot showing the fraction of PAX6+, KI67+ and NEUN+ in E14 primary 
cortical cells 48 h after transfection in vitro (n = 3 embryos each).  
b, i, Line graphs show mean ± s.e.m. as a transparent band in the same 
colour; control shRNA and Akna shRNA no. 1 data in b and control 
shRNA in i are the same data as shown in Fig. 1e. Box plots show median, 
quartiles (box) and range (whiskers); b, f, i–k, two-sided Mann–Whitney 
U test; l, two-sided Students t-test. Scale bars, 50 μm.
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Extended Data Fig. 6 | AKNA is sufficient to mediate microtubule 
polymerization and recruit γTuRC, CKAP5 and SDA components. 
a–e, Micrographs of E14 primary cortex cells treated and immunostained 
as indicated. a, Time series depicting regrowth of the microtubule 
cytoskeleton after nocodazole-mediated depolymerization (n = 3 
experiments). b, Regrowth of the microtubules 60 s after nocodazole-
mediated depolymerization in AKNA overexpression (GFP+) cells (n > 10 
experiments). Red arrows indicate centrosomes. Note that microtubules 
polymerize also from ectopic AKNA+ sites. c, Confocal images showing 
co-labelling of AKNA foci with the γTuRC components TUBG and GCP4, 
and microtubule nucleation factor CKAP5 (n = 2 experiments).  
d, Confocal micrographs illustrating that AKNA foci fail to recruit PCNT, 
NEDD1 and the microtubule minus-end capping-proteins CAMSAP2, 
CEP170 and CLASP2 (n = 2 experiments). e, Confocal micrographs 
depicting co-localization of ectopic AKNA foci with ODF2, DCTN1, EB1, 
dynein and CAMSAP3 (n = 2 experiments; 4 experiments for CAMSAP3). 
f, Co-immunoprecipitation experiments with lysates from E14 cerebral 
cortex, immunoprecipitation with AKNA antibody and western blot with 
AKNA, ODF2, DCTN1, EB1 AND GCP2, showing that these proteins are 
in the same complex, except GCP2 (that is, γTuRC) (n = 2 independent 
experiments for each). Scale bars, 5 μm (a–e).
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Extended Data Fig. 7 | AKNA effects on cilia formation or localization, 
the upstream regulation of Akna, and summary of AKNA effects.  
a, b, Histograms depicting the percentages of ciliated cells (ARL13+)  
(a, n = 4 independent experiments) and short versus long cilia (b, n = 4 
independent experiments), in E14 primary cortical cells transfected with 
control shRNA or Akna shRNA. Short cilia are defined as dot-like (short 
axoneme or cilium not fully exposed to cell surface), and long cilia are 
defined as rod-shaped (long axoneme exposed at the cell surface).  
c, d, Integrated correlative light and electron microscopy micrographs of 
in utero-electroporated cells (n = 2 embryos). The images compare two 
neighbouring NSCs; one electroporated (blue) and one non-electroporated 
(orange). Yellow and pink arrows show anti-GFP and anti-TUBA 
immunogold signal in the cytoplasm and cilium of the electroporated cell. 
Notice that AKNA electroporation does not notably affect cilia formation 
in vivo. e, Confocal micrographs of CAMSAP3, CDH2 (N-cadherin)  
and F-actin staining in E14 cortex. i, Model describing the expression  
and functional role of AKNA in delamination and seeding of the SVZ.  
j. Schematic indicating and summarizing the modes of AKNA function in 
NSC delamination. Data in a, b are presented as mean ± s.e.m. Scale bars, 
30 μm (c, immunofluorescence), 1 μm (c, electron microscopy), 0.1 μm 
(d), 25 μm (e).
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Extended Data Fig. 8 | CAMSAP3 in the developing cortex, AKNA 
binding to and effects on purified microtubules, and AKNA regulation 
and function during EMT in mammary epithelial cells. a–c, AKNA 
overexpression in E14 cortex influences both the orientation  
(a, b, control, 117 EB3-comets; AKNA overexpression, 122 EB3-comets 
in 3 experiments; plot shows the distribution and solid line indicates 
the mean, ± s.e.m. as transparent band) and speed (c, control, 178 
EB3-comets; AKNA overexpression, 113 EB3-comets) of microtubule 
polymerization monitored by live imaging of EB3–GFP in cortical slices 
1 day after IUE. d, Representative kymographs obtained from TIRF time-
lapse images of microtubules assembled in vitro from bovine brain tubulin 
labelled with Cy5 in the presence of AKNA–GFP. Cy5 is shown in red 
and GFP in green. e–g, Dynamic instability parameters of microtubules 
assembled from bovine brain tubulin with and without AKNA. Tubulin 
concentration was 15 μM and AKNA concentration was 75 ng ml−1.  
In reactions containing AKNA, the growth velocity was increased. 
Moreover, the mean depolymerization velocity of shrinking plus ends 
without an AKNA signal was 0.27 μm s−1, and the mean velocity was 
0.10 μm s−1 when AKNA was associated with the plus end (g).  
e, f, Microtubule, n = 117; microtubule and AKNA, 174; g, microtubule, 
n = 84; microtubule and AKNA, n = 47 single measurements made from 2 
(microtubule) and 3 (microtubule and AKNA) independent experiments. 
h, Box plot showing marker expression 24 h after IUE of GFP (control) 
(n = 4 embryos), AKNA overexpression (n = 4 embryos) and AKNA 
overexpression supplemented with Taxol (20 μM) (n = 6 embryos). GFP 
(control) and AKNA overexpression is the same data as shown in Fig. 1j. 
Note that the addition of Taxol during IUE rescues the phenotype of 
AKNA overexpression. i, Bar graph illustrating the mRNA expression 
of Twist1, Zeb2, Snai1, Snai2 and Fn1 by qRT–PCR (n = 3 individual 
experiments) after TGFβ1 treatment and siRNA transfection (data are 
shown as mean ± s.e.m.). j, AKNA immunofluorescence in untreated  
and TGFβ1-treated (two-day treatment) NMuMG cells. Red arrows 
indicate AKNA− centrosomes (PCNT+) in untreated cells, and blue  
arrows indicate AKNA+ centrosomes in TGFβ1-treated cells.  
k, Western blot showing AKNA protein increase during the first days 
after EMT induction, and subsequent decrease to levels similar to those 
in untreated cells. Coomassie-stained gel showing equal loading is 
shown below. l, Dot and violin plot depicting the EB3–GFP fluorescence 
intensity measured at the centrosome in control (Centrin–tdTomato) and 
AKNA–mKO2 overexpression NMuMG cells, indicating the increased 
centrosomal microtubule nucleation after AKNA overexpression (GFP, 
57 cells; AKNA overexpression, 56 cells). m, Western blot of AKNA and 
de-tyrosinated tubulin in untreated cells, and in cells transfected with 
control and Akna siRNA after four days of TGFβ1 treatment. Note the 
efficient knock down of AKNA by siRNA treatment, and the concomitant 
increase in detyrosinated tubulin. Whole protein detection illustrating 
equal protein loading is shown below. n, Western blot of TUBA and 
detyrosinated tubulin in control (GFP) and AKNA overexpression-
transfected NMuMG cells 12 h after transfection. Note the decrease 
in detyrosinated tubulin upon AKNA overexpression. o, Micrograph 
illustrating how the quantification for ZO-1 was performed in p. p, Line 
graph depicting the quantification of ZO-1 intensity profiles across cells 
along white lines (see also Fig. 3a) (untreated, n = 60 cells; TGFβ1-treated, 
control siRNA, n = 55 cells; TGFβ1-treatment, Akna siRNA, n = 76 cells; 
cell junctions = position 0). *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 (exact  
P values (from left to right) 5.2 × 10−6, 0.00004 and 0.04177). q, Line 
graph depicting the quantification of CAMSAP3 intensity profiles 
across cells, as indicated in Fig. 3e (untransfected, n = 26 cells; AKNA 
overexpression, n = 22 cells). NS, not significant, ***P ≤ 0.001 (exact  
P values (from left to right) 0.53142 and 0.00003). r, Line graph depicting 
the quantification of CAMSAP3 intensity profiles across cells, as in Fig. 3e 
(untreated, n = 42 cells, TGFβ1-treated and control siRNA, n = 51 cells; 
TGFβ1-treated and Akna siRNA, n = 50 cells). *P ≤ 0.05, ***P ≤ 0.001 
(exact P values (from left to right) 0.02478, 0.00038, 0.00095 and 0.00086). 
f–h, Box plots show median, quartiles (box) and range (whiskers). c, e, l,  
Violin plots show distribution of individual measurements (dots) with 
mean ± s.e.m. in bold in the centre (two-sided Mann–Whitney U test). 
Scale bars, 5 μm (j), 25 μm (a).
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Extended Data Fig. 9 | See next page for caption.
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Extended Data Fig. 9 | Lower levels of AKNA in differentiating neurons 
mediate non-centrosomal microtubule polymerization and allow 
migration into the cortical plate. a, b, Primary E14 cortical cells were 
sorted for PROMININ 1 (CD133) to isolate NSCs or for PSA-NCAM to 
isolate neurons as indicated in the panels. PROM1+ cells express the NSC 
marker nestin, whereas PSA-NCAM+ cells express the neuronal marker 
TUBB3, showing the specificity of the FACS (a) (n = 2 independent 
experiments). Microtubule regrowth assay in purified NSCs shows 
centrosomal microtubule polymerization (b, top), and purified neurons 
show largely non-centrosomal microtubule polymerization patterns  
(b, bottom) (n = 2 independent experiments). c, Micrographs showing 
co-electroporation of a CAG–dsRED and DCX–GFP at E13 and analysis 
at E15. Note the onset of Dcx–GFP expression (c′′) only in the SVZ and 
cortical plate of the developing cortex, whereas DsRED+ cells are also 
found in the ventricular zone (c, c′) (n = 3 embryos). d, e, Micrographs 
showing electroporated cells (GFP+) in control (Dcx-GFP) (d) and 
Akna overexpressing (Dcx-Akna) (e) conditions (n = 3 embryos each 
conditions). Note that many AKNA overexpression cells accumulate in 
the SVZ, and are unable to migrate into the cortical plate. f, Micrographs 
of AKNA overexpression cells retained in the SVZ co-stained for TBR1, 
CTIP2, AND CUX1, which label neurons of different layer identity (n = 3 
embryos). Note that the neuronal populations accumulating below the 
cortical plate upon Dcx-driven Akna expression contain neurons that are 
positive for each of these neuronal identities. g, Micrographs showing 
that electroporated cells (GFP+) after control and Dcx-driven miRNA 
mediated downregulation of AKNA enter the cortical plate equally well 
(n = 3 embryos). h, Line graph illustrating the distribution of GFP+ 
cells after IUE for Dcx-miRNA(neg), and Dcx-Akna miRNA no. 4. 
Mean ± s.e.m. as a transparent band (Dcx-miRNA(neg), n = 4; Dcx-Akna 
miRNA no. 4, n = 3 embryos). Scale bars, 5 μm (a, b), 50 μm (c–g).
Letter reSeArCH
Extended Data Fig. 10 | See next page for caption.
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Extended Data Fig. 10 | AKNA localization in ferret and macaque 
cerebral cortex and function in human cerebral cortex organoids.  
a, b, RT–qPCR of Akna and Sox4 in untreated or TGFβ1-treated 
NMuMG cells (treated for two days) showing upregulation during EMT 
(n = 4 independent experiments, mean ± s.e.m.). c, RT–qPCR of Akna 
after SOX4 overexpression in N2A cells for 36 h (n = 4 independent 
experiments, mean ± s.e.m.). d, qRT–PCR for Akna, showing the transient 
but strong upregulation of Akna mRNA in ferret ventricular zone tissue 
at E34—the time at which cells that form the outer SVZ (oSVZ) leave the 
ventricular zone32 (n = 4 (E30), 7 (E34), 4 (P1) biologically independent 
samples). e, f, Microarray33 (n = 3 biologically independent samples) (e) 
and western blot (f, 3 independent experiments) data showing higher 
levels of AKNA in the lateral sulcus (LS) compared to splenial gyrus (SG) 
in the oSVZ tissue of ferret brain at P1. g, Micrograph showing AKNA and 
TUBG co-localization at centrosomes in ferret brain cells (3 independent 
experiments). h, i, Comparison of AKNA immunofluorescence in ferret 
ventricular zone and oSVZ tissue in splenial gyrus versus lateral sulcus. 
Note the more-abundant immunofluorescence signal in the oSVZ of 
the lateral sulcus, corresponding with mRNA and protein levels as 
determined by western blot (n = 2 biologically independent samples). 
Given that the oSVZ of the gyrus contains more basal radial glia with 
bipolar morphology than does that of the sulcus, we propose that AKNA 
levels regulate the multipolar-to-bipolar transition in ferret SVZ, as 
AKNA levels do in mouse SVZ, with higher levels of AKNA leading to 
the retention of more cells in a multipolar state (see Fig. 4g–j). j, k, AKNA 
immunofluorescence in developing macaque germinal zone (GZ) and 
cortical plate (n = 2 sections from 2 animals). Arrows indicate AKNA+ 
centrosomes and denote abundant immunofluorescence signal. The square 
in j shows a representative example of a TUBG+AKNA+ centrosome in 
the germinal zone, and the square in (k) depicts an AKNA− centrosome 
in the cortical plate. l, Micrographs of human NPCs derived from 
hiPSCs that overexpress AKNA, showing multiple foci of microtubule 
polymerization (n = 2 independent experiments). m, n, In situ 
hybridization in hiPSC-derived cerebral organoids showing enrichment 
of Akna mRNA in non-apical SVZ-like areas (representative images of 
ventricular-zone-like structures from organoids of two independent 
culture batches). o, p, Micrographs showing sections of human brain 
organoids stained for GFP+ cells, electroporated with a control plasmid 
(o) or a plasmid overexpressing human AKNA cDNA (p). q, Line graph 
illustrating the distribution of GFP+ cells after IUE for GFP and AKNA 
overexpression (GFP, n = 36 ventricular zones; AKNA overexpression, 
n = 37 ventricular zones out of 2 independent organoid culture batches). 
r, Line graph illustrating the distribution of GFP+ electroporated cells 
after IUE for control miRNA and Akna miRNA knock down (control 
miRNA, n = 36 ventricular zones; Akna miRNA, n = 31 ventricular zones 
out of 2 independent organoid culture batches). q, r, Line graphs show 
mean ± s.e.m. as transparent band in the same colour. a–c, e, Two-sided 
Students t-test; d, one-way ANOVA followed by Tukey’s post hoc test;  
q, r, two-sided Mann–Whitney U test. Scale bars, 5 μm (g), 50 μm  
(h, i, m, n), 10 μm (l, j, k).
 32. Martínez-Martínez, M. A. et al. A restricted period for formation of outer 
subventricular zone defined by Cdh1 and Trnp1 levels. Nat. Commun. 7, 11812 
(2016).
 33. de Juan Romero, C., Bruder, C., Tomasello, U., Sanz-Anquela, J. M. & Borrell, V. 
Discrete domains of gene expression in germinal layers distinguish the 
development of gyrencephaly. EMBO J. 34, 1859–1874 (2015)
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) 
AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection Movies and immunofluorescence images: Olympus FV1000 confocal laser-scanning microscope FV 4.2, DeltaVision Core system, LEICA 
DM 6000 CS SP5 system LAS X 3.4, Leica SP8X STED 3D DLS LAS X 3.4, Axioplan2 epifluorescence microscope (Zeiss) Zen 2.0, Nikon A1 
confocal microscope, Zeiss Super Resolution LSM880 AiryScan Elyra S1 Zen 2.3, Zeiss Z1 Axio Observer microscope with Yokogawa CSU-
X1 spinning disk unit Zen 2.0, motorized inverted Nikon Eclipse Ti-E microscope with a motorized TIRF angle . Electron Microscopy: 
Morgagni EM at 80 kV (FEI) with a Morada camera. Western blots: Curix 60 (AGFA) with ECL method on Röntgen films (Fujifilm), 
ChemiDoc XRS (BioRad, 5.2.1). Mass spectrometry: Q Exactive high field mass spectrometer (Thermo Fisher) coupled to a RSLC HPLC 
system (Ultimate 3000, Thermo Fisher). FACS: Aria Cell Sorters (BD Biosciences, FACSDiva 6.1.3)
Data analysis R Studio (1.1.456), R (3.5.1), GraphPad Prism (7.04), Python (3.6.5). Movies and IF: Fiji/ImageJ (2.0), ND acquisition software (Nikon), 
Picasso software suite (0.2.4; Endesfelder et al., 2014, 10.1007/s00418-014-1192-3), Imaris Software (Bitplane, 8.2), Huygens Software 
(SVI, 14.8-14.10), Leica LAS X 3.4. EM: ITEM software (EMSIS, 5.1 build 2677). WB: Image Lab Software (BioRad 5.2.1). MS: Progenesis QI 
software (Nonlinear, Waters, 2.5), Mascot (MatrixScience, London, UK; version 2.5.1) with Ensembl mouse public database,  FACS: BD 
FACSDiva (6.1.3) and Flowjo (10.2) software
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. 
We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
The datasets generated in this study have been made available as Supplementary Information (and Supplementary Table 2). Further data are available upon 
reasonable request from the corresponding author.
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For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size No statistical methods were used to predetermine sample sizes. Sample size were predetermined on the basis of published studies. All 
quantitative experiments in this study were repeated at least three times. For in vivo experiments the number of embryos subjected to a 
particular experiment are defined by the number of embryos available in the mice operated and the statistical requirements.
Data exclusions No samples, no animals and no data was excluded
Replication All experiments in this study, except the proteomic analysis in Extended Data Fig.  1o,  were replicated multiple times with the same 
experimental protocol, followed by the same analysis. All replications were successful and showed the same results. 
Randomization All animals, human cerebral organoids and wells of cultured cells were assigned to groups randomly
Blinding Blinding was not possible, due to the very strong phenotype after Akna manipulation (see Fig. 1, 2 ,4). Quantifications in Fig. 3 were analysed 
in a blinded manner. 
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
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Antibodies used Commercial primary antibodies are:  
Akna (DSHB, clone 1C7, mouse, 1:25), Arl13b (ProteinTech 17711-1AP, rabbit, 1:200, lot 00040297), Actb (C4) (Santa Cruz 
sc-47778, mouse, 1:1000, lot F1417), CAMSAP2 (ProteinTech 17880-1-AP, rabbit, lot 00009360), Cdh2/N-Cadherin (BD 
Transduction Laboratories 610921, mouse, clone 32/N-Cadherin, 1:250, lot 46226), Clasp2 (Millipore ABT263, rabbit, 1:200, 
3040386), Cep170 (Novus NB100-55317, rabbit, 1:200, lot A1), Ckap5 (H4) (Santa Cruz sc-374394, mouse, 1:50, lot G0716), Ctip2 
(Abcam ab18465, rat, clone 25B6, 1:250, lot GR243609-2), Cux1/CDP (M-222) (Santa Cruz sc-13024, rabbit, 1:50 to 1:500, lot 
F0315),   CyclinD1 (Thermo Fisher RM9104R7, rabbit, 1:500, lot 910R1107C), Dynein IC (Millipore, MAB1618, mouse, clone 74.1, 
1:100 to 1:500, lot 2876150), Dctn1 (H-300) (Santa Cruz sc-11363, rabbit, 1:50 to 1:500, lot F2609), Dctn1/p150Glued (BD 
Transduction Laboratories 612709, mouse, Clone  12/P150GLUED, 1:100 to 1:1000, lot 5192749), Dctn2 (H-300) (Santa Cruz 
sc-135135, rabbit, 1:500, lot F2410), Dctn4 (Abcam ab170107, rabbit, 1:500 to 1:2000, lot YJ121404DS), Dcx (Millipore AB2253, 
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guinea pig, 1:1000, lot 2787730), EB1 (H-70) (Santa Cruz sc-8356, rabbit, 1:50 to 1:1000, lot K1709), E-Cadherin (DECMA-1) 
(Abcam ab11512, rat, 1:500, lot GR3215680-2), FLAG – M2 (Sigma F1804, mouse, 1:500, lot SLBN2445V), Gapdh (Millipore 
MAB374, mouse, clone 6C5, 1:1000 to 1:3000, lot NG1722294), GCP2 (Novus NBP2-21793, mouse, clone GCP2-01, 1:500, lot 
525992), GCP2 (F3) (Santa Cruz sc-377117, rabbit, 1:500, lot AS2114), GCP4 (D-5) (Santa Cruz sc-271876, rabbit, 1:100, lot 
B0414), GFP (Aves Lab GFP-1020, chicken, 1:1000, lot 0511FP12), GT335 (AdipoGen AG20B-0020, mouse, clone GT335, 1:2000, 
lot A20631002), Histone H3 (Abcam ab1791, rabbit, 1:1000 to 1:5000, lot GR2100231), Ki67 (Leica/Novocastra NCL-Ki67p, 
rabbit, 1:200, lot PA 0230 44924), Ki67 (Abcam ab92742, rabbit, clone EPR3610, 1:500, lot GR213055-34), Ki67 (Invitrogen/
Thermo Fisher 14-5698-82, rat, clone SolA15, 1:500, lot 2002315), NEDD1 (39-J) (Santa Cruz, sc-100961, mouse, 1:50 to 1:100, 
lot L2914), Nestin (Millipore MAB353, mouse, clone rat-401, 1:500, lot 2041569), NeuN (Millipore MAB377, mouse, clone A60, 
1:500, lot 2549411), Odf2 (Abcam ab43840, rabbit, 1:200, lot GR127791-1), Odf2 (G-2) (Santa Cruz sc-393881, mouse, 1:50 to 
1:500, lot A2414), Ctnnd1/p120 (Abcam ab92514, rabbit, 1:500, lot GR19086717), p53 (Cell Signaling 2524, mouse, clone 1C12, 
1:500, lot 13), p-120 (Abcam ab81318, rabbit, 1:500, lot YF071003C), Pan-Cadherin (Sigma C3678, rabbit, 1:500, lot 093164870), 
Pax6 (Millipore AB2237, rabbit, 1:500, lot 2910153), Pax6 (DSHB AB 528427, mouse, 1:25, home-made hybridoma sypernatant), 
PCNA (DAKO M0879, mouse, clone PC10, 1:500, lot 00083603), Pcnt (Biologend 923701, rabbit, 1:500, lot B200667), Phalloidin-
Atto 647N (Sigma, 65906, lot BCBW3497), p-Histone H3 (Ser10) (Millipore 06-570, rabbit, 1:500, lot 2517793), RFP (Rockland 
600401379, rabbit, 1:500, lot 35055), Tbr1 (Abcam ab31940, rabbit, 1:200, lot GR204561), Tbr2 (Millipore AB15894, chicken, 
1:500, lot 2391191), Tbr2 (Abcam ab23345, rabbit, 1:250, lot GR153320-1), Tbr2 (Abcam ab183991, rabbit, clone EPR19012, 
1:500, lot GR2883504), Tuba (Sigma T5168, mouse, clone B-5-1-2, 1:1000 to 1:20,000, lot 103M4773V), Tuba (Thermo Fisher 
MA1-80017, rat, 1:200), Tubb3 (Sigma T8660, mouse, clone SDL.3D10, 1:1000, lot 103M4830), Tubg (Sigma T6557, mouse, clone 
GTU-88, 1:250, lot 070M4856), Tubg (Sigma T5192, rabbit, 1:200, lot 109K4802), Tubg (ProteinTech 15176-1-AP, rabbit, 1:200, 
lot2578104), Tubulin acetylated (Sigma T7451, mouse, clone 6-11b-1, 1:2000, lot 103M4772V), Tubulin tyrosinated (Sigma 
MAB1864-I, rat, clone YL1/2, 1:5000, lot GR3187372-2), Tubulin detyrosinated (Millipore AB3201, rabbit, 1:1000, lot 2886375), 
ZO-1 (Invitrogen 617300, rabbit, 1:500 to 1:2500, lot SH252320). For flow cytometry PSA-NCAM PE-coupled (Miltenyi 
130-093-274, mouse, clone 2-2B, 1:750, lot 5150810207) and CD133 APC-coupled (eBioscience 17-1331, rat, clone 13A5, 1:500, 
lot 4290710) were used. 
 
Commercial secondary antibodies are:  
mouse IgG HRP (Invitrogen 62-6520, goat, 1:10,000, lot SI257293), rat IgG HRP (Ge Healthcare Life Sciences NA935, goat, 1:5000, 
lot 9700734), rabbit IgG HRP (Ge Healthcare Life Sciences NA934-1ML, donkey, 1:10,000, lot 16885523), mouse IgG HRP 
(Rockland 18-8817-30, rat, 1:1000, lot 32642), rabbit IgG HRP (Rockland 18-8816-31, mouse, 1:1000, lot 34665), goat IgG HRP 
(Chemicon AP106p, rabbit), rat unconjugated (Jackson ImmunoResearch/Dianova 712-005-150, donkey), chicken A488 (Thermo 
Fisher A11039, goat, lot 1637891), chicken A546 (Thermo Fisher A11040, goat, 1094435), rat A488 (Thermo Fisher A11006, goat, 
lot 1689880), rat A546 (Thermo Fisher A11081, goat, lot 1661229), rat A647 (Thermo Fisher A21247, goat, lot 16543056), rabbit 
A488 (Thermo Fisher A11008, goat, lot 1735088), rabbit FAB 488 (Jackson ImmunoResearch 711-547-003 donkey, lot 128821), 
rabbit A546 (Thermo Fisher A11010, goat, lot A11010), rabbit A568 (Thermo Fisher A11011, goat), rabbit A633 (Thermo Fisher 
A21070, goat, lot 1739295), rabbit A647 (Thermo Fisher A21244, goat, lot 1696456), guinea pig A488 (Thermo Fisher A11073, 
goat, lot 52959A), guinea pig A546 (Thermo Fisher A11074, goat, lot 1716235), mouse IgG A488 (Thermo Fisher A11029, goat, 
lot 1306597), mouse IgG1 A488 (Thermo Fisher A21121, goat, lot 719913), mouse IgG1 A546 (Thermo Fisher A21123, goat, lot 
1722393), mouse IgG1 A647 (Thermo Fisher A21240, goat, lot 1661240), mouse IgG2a A488 (Thermo Fisher A21131, goat, lot 
1145164), mouse IgG2a A546 (Thermo Fisher A21133, goat, lot 1694115), mouse IgG2b A488 (Thermo Fisher A21141, goat, lot 
1512106), mouse IgG2b A546 (Thermo Fisher A21143, goat, lot 1711516), rabbit AS635P (Abberior 2-0012-007-2, goat, 1:200, 
lot 18012016HP), mouse IgG AS580 (Abberior 2-0002-005-1, goat, 1:200, lot 22012016CW). *A = Alexa Fluor; ** AS = Abberior 
Star. Unless otherwise described, fluorencent labelled secondary antibodies were used at a dilution of 1:500 to 1:1000. HRP-
coupled  secondary antibodies were used at a dilution of 1:5000 to 1:10,000. 
 
Isotypes controls are:  
IgG1 isotype (Biolegend 401402, mouse, clone MG1-45, lot B197935), normal IgG (Santa Cruz sc-2027, rabbit, lot H2615), IgM 
isotype PE (Miltenyi 130093177, mouse, clone IS5-20C4, 1:750, lot 5170328287), IgG1 isotype APC (eBioscience 17-4301, rat, 
clone eBRG1, 1:500, lot E07258-1632) 
 
Home-made antibodies are: Akna (25F1, mouse IgG1, IF (1:25-1:100)), Akna (14D7, rat IgG2a, WB (1:10), IF (1:25-1:100)), AKNA-
A (9G1, rat IgG1, WB (1:10), IF (1:25-1:100)), AKNA-B (4F5, rat IgG2a), WB (1:10), IF (1:25-1:100)), HA (mouse IgG1, for IP used 1 
ml supernatant), Camsap3 (kind gift of Masatoshi Takeichi, RIKEN CDB, Meng et al., 2008, 10.1016/j.cell.2008, rabbit, 1:100 to 
1:500), Cas9 (8G1-1-1, rat IgG2a, WB (1:10)), Sox4 (kind gift of Elisabeth Sock, University of Erlangen-Nürnberg, Hoser et 
al.,2008, 10.1128/MCB.00338-08,, guinea pig, 1:2000) 
Validation Antibodies were validated by the manufacturer and corroborated with previously published antibody staining results. Home 
made antibodies were validated by immunofluoresence and/or Western Blot and RNAi.
Eukaryotic cell lines
Policy information about cell lines
Cell line source(s) Neuro2A: Oskar Ortiz, Institute for Developmental Genetics, Helmholtz Center München, Germany (ACC 148, DSMZ, 
Braunschweig, Germany) 
NMuMG: Vijay Tiwari Institute for Molecular Biology, Mainz, Germany (clone NMuMG/E9, from ATCC-CRL-1636)  
human iPS cells: Micha Drukker, Institute for Stem Cell Research, Helmholtz Center München, Germany (line HMGU1) and 
the Universitätsklinikum Erlangen (Havlicek et al., 2013; 10.1093/hmg/ddt644) 
A20: Elisabeth Kremmer, Core Facility Monoclonal Antibodies, Helmholtz Center München, Germany (ATCC TIB-208) 
Mpf cells: Victor Borrell, Instituto de Neurociencias, Universidad Miguel Hernández (Mpf ATCC CRL-1656)
Authentication iPS cells were authenticated after reprogramming by karyotyping. 
The cell lines Neuro2A, NMuMG, A20, Mpf  were not authenticated.
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Mycoplasma contamination Human iPS cells and the human iPS cells derived cerebral organoids were tested negative for mycoplasma.  
The cell lines Neuro2A, NMuMG, A20, Mpf were not tested for mycoplasma.
Commonly misidentified lines
(See ICLAC register)
No commonly misidentified cell line was used in this study. 
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals Female and male mice were used at embryonic stages E9, E11, E13, E14, E15, E18.  C57BL/6J  and RjHan:NMRI mice at 2 to 12 
months of age were bred and time mated in house, or purchased from Charles River or Janvier, and used as a source for 
embryonic brain tissue, for in utero electroporations or monoclonal antibody generation. 2 to 12 months of old Sas4fl/fl; p53fl/fl; 
Emx1Cre were generated by the Song-Hai Shi lab (Insolera et al., 2014, 10.1038/nn.3831) to produce E14 embryos. Lou/C rats 
were bred in house at the HMGU and used for monoclonal antibody generation (90-150 days old). Pregnant female pigmented 
ferrets (Mustela putorius furo) were obtained from Marshall Farms and embyos (E30, E34)  or neonaltal (P1) animals were used 
for experiments. Embryos (E64) of pregnant female cynomolgus monkeys (Macaca fascicularis) were used to obtain embryonic 
macaque brain tissue as describe in the methods.
Wild animals The study did not involve wild animals.  
Field-collected samples The study did not involve samples collected from the field.
Ethics oversight Mice: all experimental procedures were performed in accordance with the regulations of the Helmholtz Center Munich, the 
Biomedical Center of the LMU, the MSKCC IACUC, and GIGA-Neurosciences University of Liège. 
Ferrets: all animals were treated according to Spanish and EU regulations, and experimental protocols were approved by the 
Universidad Miguel Hernández IACUC.  
Cynomolgus monkey (Macaca fascicularis):  the cynomolgus monkey facility in this study and all experimental protocols were 
approved by the Animal Care and Use Committee CELYNE (C2EA#42). Surgical procedures and animal experimentation were in 
accordance with European requirements 2010/63/UE. Protocols C2EA42-12-11-0402-003 and APAFIS#3183 have been approved 
by the Animal Care and Use Committee CELYNE (C2EA #42)" 
iPS cells: The use of iPSCs  was approved by the Ethics Commission of LMU (Ludwig-Maximilians-Universität München), with the 
association number 115-16. Lines were derived from male newborn foreskin fibroblasts (CRL-2522, ATCC) or from healthy 
patient fibroblasts obtained following Institutional Review Board approval no. 4120 and informed patient consent at the 
Movement Disorder Clinic at the Department of Molecular Neurology, University Clinic Erlangen, Germany.




The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation Cortices from E14 embryos were dissected removing the ganglionic eminence, the olfactory bulb, the hippocampal anlage and 
the meninges. Single cells wereincubated with an APC-conjugated Prominin-1 antibody (CD133, eBioscience) or PE-conjugated 
PSA-NCAM antibody (Miltenyi Biotec).  
 
Sorted cells were examined through plating and immunohistochemistry (fixation 2-4 hours after plating) which confirmed their 
expected NSC (Pax6 positive) and neuronal identity (βIII-Tubulin positive) and the purity of the sorting procedure. 
Instrument Cells were isolated on Aria Cell Sorters (BD Biosciences)
Software Data were analized with BD FACSDiva and Flowjo software
Cell population abundance N/A (see above)
Gating strategy Gating parameters were determined by side and forward scatter to eliminate debris (P1 gate) and aggregated cells (P2 gate). PE- 
and APC conjugated isotype control (eBioscience, Miltenyi Biotec) stained cells were used to set the positive and negative gates 
for the stained populations (both set to include maximum 0.1% of non-fluorescent cells). 
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
